Easywell Biomedical Overview
- Year Founded
-
1998
- Status
-
Public
- Employees
-
229
- Stock Symbol
-
1799
- Investments
-
4
- Share Price
-
$0.76
- (As of Thursday Closing)
Easywell Biomedical General Information
Description
Easywell Biomedicals Inc is engaged in drug development, manufacturing, and sales of active pharmaceutical ingredients, generic drugs, and new drugs. It focuses on complex generics, new drug delivery platforms, and regenerative medicines, with cGMP. The company's segments include the Drug Development segment and the Other segment. Geographically, the company operates in America, China, and Taiwan regions.
Contact Information
Website
www.easywellbio.comCorporate Office
- Number 10, R&D 2nd Road
- Science Park
- Hsinchu
- Taiwan
Corporate Office
- Number 10, R&D 2nd Road
- Science Park
- Hsinchu
- Taiwan
Easywell Biomedical Stock Performance
As of 12-Nov-2026, Easywell Biomedical’s stock price is $0.76. Its current market cap is $94.8M with 125M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.76 | $0.74 | $0.72 - $1.43 | $94.8M | 125M | 117K |
Easywell Biomedical Financials Summary
As of 30-Jun-2026, Easywell Biomedical has a trailing 12-month revenue of $25.8M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 121,668 | 143,371 | 239,139 | 157,193 |
| Revenue | 25,751 | 19,150 | 16,841 | 8,721 |
| EBITDA | 3,326 | 1,137 | 244 | (2,855) |
| Net Income | (503) | (2,344) | (3,037) | (4,649) |
| Total Assets | 40,504 | 41,322 | 45,776 | 39,501 |
| Total Debt | 12,119 | 13,619 | 17,160 | 12,573 |
Easywell Biomedical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Easywell Biomedical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Easywell Biomedical Patents
Easywell Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D723396-S1 | Ear thermometer | Active | 14-Nov-2013 | ||
| DE-202013101424-U1 | Electrochemical test plate with hemofilter function | Inactive | 03-Apr-2013 | ||
| DE-102013109524-A1 | A pretreatment device and method for biochemical reactions | Inactive | 22-Feb-2013 | ||
| US-20140242718-A1 | Pretreatment device and method for biochemical reaction | Inactive | 22-Feb-2013 | ||
| US-20140209486-A1 | Detecting device and method applying a detecting strip | Inactive | 28-Jan-2013 | G01N27/3273 |
Easywell Biomedical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Easywell Biomedical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Easywell Biomedical Investments & Acquisitions (4)
Easywell Biomedical’s most recent deal was a Merger/Acquisition with Jianya Biotechnology for . The deal was made on 28-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Jianya Biotechnology | 28-Jul-2026 | Merger/Acquisition | Pharmaceuticals | ||
| Jiangsu Huahan Pharmaceutical | 24-Oct-2024 | Secondary Transaction - Private | Pharmaceuticals | ||
| Jiangsu Huahan Pharmaceutical | 13-Feb-2020 | Merger/Acquisition | Pharmaceuticals | ||
| Transwell Biotech | 01-Jan-2016 | Merger/Acquisition | Biotechnology |
Easywell Biomedical ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Easywell Biomedical Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Jiangsu Huahan Pharmaceutical | Nanjing, China | 2019 | |
| Transwell Biotech | Hsinchu, Taiwan | 2010 | |
| Jianya Biotechnology | Hsin-Chu, Taiwan | 1993 |
Easywell Biomedical FAQs
-
When was Easywell Biomedical founded?
Easywell Biomedical was founded in 1998.
-
Where is Easywell Biomedical headquartered?
Easywell Biomedical is headquartered in Hsinchu, Taiwan.
-
What is the size of Easywell Biomedical?
Easywell Biomedical has 229 total employees.
-
What industry is Easywell Biomedical in?
Easywell Biomedical’s primary industry is Drug Delivery.
-
Is Easywell Biomedical a private or public company?
Easywell Biomedical is a Public company.
-
What is Easywell Biomedical’s stock symbol?
The ticker symbol for Easywell Biomedical is 1799.
-
What is the current stock price of Easywell Biomedical?
As of 12-Nov-2026 the stock price of Easywell Biomedical is $0.76.
-
What is the current market cap of Easywell Biomedical?
The current market capitalization of Easywell Biomedical is $94.8M.
-
What is Easywell Biomedical’s current revenue?
The trailing twelve month revenue for Easywell Biomedical is $25.8M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
